U.S. Naval Medical Research Unit No. 3 (NAMRU-3), Cairo, Egypt.
J Infect Public Health. 2009;2(2):74-80. doi: 10.1016/j.jiph.2009.04.004. Epub 2009 May 27.
In December 2006, three human specimens were received that were suspected positive for influenza A(H5N1). The specimens were tested using real time PCR. And the presence of A(H5N1) virus was confirmed in 2 patients (16F and 26M), The NA sequence from A(H5N1) positive specimens collected before and after antiviral therapy revealed a mutation (N294S) (N295S according to N1 numbering), previously associated with resistance to oseltamivir. When tested with NA inhibition assays, the two N294S viruses from Egypt exhibited from 57 to 138-fold reduction in susceptibility to oseltamivir, depending on the assay. To our knowledge, this is the first time oseltamivir resistance has been detected in A(H5N1) infecting a human prior to treatment.
2006 年 12 月,收到了三个人类疑似感染甲型 H5N1 流感的样本。使用实时 PCR 对这些样本进行了检测。在 2 名患者(16F 和 26M)中确认存在 A(H5N1)病毒。对在抗病毒治疗前后采集的 A(H5N1)阳性样本的 NA 序列进行分析发现,存在一个先前与奥司他韦耐药相关的突变(N294S)(根据 N1 编号为 N295S)。当用 NA 抑制测定法进行检测时,来自埃及的两种 N294S 病毒对奥司他韦的敏感性降低了 57 至 138 倍,具体取决于测定法。据我们所知,这是在人类感染 A(H5N1)病毒之前在未经治疗的情况下首次检测到奥司他韦耐药性。